NASDAQ · Price History

Citius Pharmaceuticals, Inc. (CTXR) Price History & Returns

$0.40 NASDAQ: CTXR Market Cap $11.07M

How Citius Pharmaceuticals, Inc. (CTXR) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $0.40 sits 2% of the way up a 52-week range of $0.37 to $2.19; 81.7% below the 52-week high; a beta of 1.00 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-37.9%
6 months-38.0%
1 year-67.4%
3 years-98.2%
5 years-98.9%
10 years+0.0%

Year by year

2 of 12 years closed higher than the year before. Closes are the last observation in each calendar year.

YearCloseChange
2026$0.40-48.7%
2025$0.78-80.5%
2024$4.00-78.9%
2023$18.92-4.2%
2022$19.75-48.7%
2021$38.50+51.0%
2020$25.50+0.0%
2019$25.50-1.9%
2018$26.00-72.6%
2017$95.00-42.9%
2016$166.50-76.0%
2015$693.75+77.9%

Monthly closing prices

The last 36 months, newest first. 9 of 36 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
October 2026$0.40-24.5%
September 2026$0.53-8.6%
August 2026$0.58+1.8%
July 2026$0.57-6.6%
June 2026$0.61-6.2%
May 2026$0.65-7.1%
April 2026$0.70-22.2%
March 2026$0.90+21.6%
February 2026$0.74+0.0%
January 2026$0.74-5.1%
December 2025$0.78-45.8%
November 2025$1.44-8.9%
October 2025$1.58+27.4%
September 2025$1.24-6.8%
August 2025$1.33-2.9%
July 2025$1.37-13.8%
June 2025$1.59+133.8%
May 2025$0.68-10.5%
April 2025$0.76-49.0%
March 2025$1.49-9.7%
February 2025$1.65-38.7%
January 2025$2.69-32.8%
December 2024$4.00+20.5%
November 2024$3.32-64.4%
October 2024$9.32-25.6%
September 2024$12.52-12.1%
August 2024$14.25-37.0%
July 2024$22.63+55.0%
June 2024$14.60-16.3%
May 2024$17.45-6.4%
April 2024$18.65-16.8%
March 2024$22.42+16.8%
February 2024$19.20+23.7%
January 2024$15.52-18.0%
December 2023$18.92-1.8%
November 2023$19.27+2.3%

Citius Pharmaceuticals, Inc. (CTXR) price history — frequently asked questions

How has Citius Pharmaceuticals, Inc. performed over the last year?

Citius Pharmaceuticals, Inc. (CTXR) has fallen 67.4% over the last twelve months, measured on price alone.

What is Citius Pharmaceuticals, Inc.'s five-year return?

Over five years the CTXR share price has lost 98.9%, excluding dividends.

What is Citius Pharmaceuticals, Inc.'s 52-week range?

Over the last year Citius Pharmaceuticals, Inc. (CTXR) has traded between $0.37 and $2.19.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.